சர்வதேச கிருமி செல் புற்றுநோய் கூட்டு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சர்வதேச கிருமி செல் புற்றுநோய் கூட்டு குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சர்வதேச கிருமி செல் புற்றுநோய் கூட்டு குழு Today - Breaking & Trending Today

Testicular, Penile, and Rare GU Malignancies


Testicular, Penile, and Rare GU Malignancies
Interviews with Experts at Conferences
Curated by clinicians: educational forums with videos, abstracts and conference information
Videos
April 27, 2021
The State-of-the-Evidence in Brief Reviews by Experts
May 17, 2021
Penile cancer (PC) is  a rare malignancy with an incidence estimated less than 1/100 000 per year in the Western World
1-3
Historically, demolitive surgical approaches, such as total or partial penile amputation, were the most commonly used. Indeed, demolitive options were deemed to be necessary in order to respect a macroscopic surgical margin of at least 2 cm.
3-4 If the oncological outcomes of these approaches demonstrated to be satisfactory, they significantly affected aesthetic outcomes, as well as sexual and urinary functions. ....

United States , New Zealand , Julien Van Damme , Pilar Laguna , Christopher Jd Wallis , Fallen James , Zachary Klaassen , Philippe Spiess , Darren Feldman , Andrea Necchi , Lucia Nappi , Philippee Spiess , Lyndal Moore , James Lynam , Silke Gillessen , Peter Albers , Alok Tewari , Andreas Hiester , Patricia Bastick , European Association Of Urology , European Multidisciplinary Congress On Urological Cancers , Moffitt Cancer Center , Global Society Of Rare Genitourinary Tumors , Cancer Trials Group , International Germ Cell Cancer Collaborative Group , Virtual Annual Congress ,

GSRGT 2020: The International Germ Cell Cancer Collaborative Group (IGCCCG) Update


GSRGT 2020: The International Germ Cell Cancer Collaborative Group (IGCCCG) Update
(Urotoday.com) The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12
th focused on testis cancer. In this session, the organizers convened a “Clinical Trials Corner” in which Dr. Silke Gillessen presented an update from the International Germ Cell Cancer Collaborative Group (IGCCCG).
As clinicians treating germ cell tumors will know, the International Germ Cell Cancer Collaborative Group published a consensus-based prognostic classification of germ cell tumors in 1997. This stratification has been widely used since that time for both clinical care and trial design. Notably, it was based on treatments delivered between 1975 and 1990, in which not all patients received cisplatin-based regimes which would now be considered standard of care. ....

United States , Vanderbilt University , Christopher Jd Wallis , Silke Gillessen , Oncology Institute Of Southern Switzerland , Global Society Of Rare Genitourinary Tumors , Head Of The Department Medical Oncology , Vanderbilt University Medical Center , International Germ Cell Cancer Collaborative Group , Department Of Oncology , Global Society , Rare Genitourinary Tumors , Professor Silke Gillessen , Medical Oncologist , Oncology Institute , Southern Switzerland , Medical Oncology , Senior Consultant , Rare Genitourinary Tumors Virtual Summit , ஒன்றுபட்டது மாநிலங்களில் , வாண்டர்பில்ட் பல்கலைக்கழகம் , கிறிஸ்டோபர் ஜ்ட் வாலிஸ் , புற்றுநோயியல் நிறுவனம் ஆஃப் தெற்கு சுவிட்சர்லாந்து , தலை ஆஃப் தி துறை மருத்துவ புற்றுநோயியல் , வாண்டர்பில்ட் பல்கலைக்கழகம் மருத்துவ மையம் , சர்வதேச கிருமி செல் புற்றுநோய் கூட்டு குழு ,

GSRGT 2020: The Need For Treatment De-Escalation In Advanced Disease: Viewpoint of the Clinical Oncologist


GSRGT 2020: The Need For Treatment De-Escalation In Advanced Disease: Viewpoint of the Clinical Oncologist
(Urotoday.com) The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12
th focused on testis cancer. In this session, Dr. Yohann Loriot presented a clinical oncologist’s perspective on the need for treatment de-escalation in advanced disease.
He began by highlighting key questions and challenges in the care of patients with germ cell tumors:
1. how to ensure the delivery of best practices for all patients.
2. how to reduce treatment burden, particularly with long-term side effects of cisplatin-based chemotherapy. ....

France General , United States , Vanderbilt University , Christopher Jd Wallis , Silke Gillessen , Yohann Loriot , Global Society Of Rare Genitourinary Tumors , Vanderbilt University Medical Center , International Germ Cell Cancer Collaborative Group , Global Society , Rare Genitourinary Tumors , European Urology , United Kingdom Based , Rare Genitourinary Tumors Virtual Summit , பிரான்ஸ் ஜநரல் , ஒன்றுபட்டது மாநிலங்களில் , வாண்டர்பில்ட் பல்கலைக்கழகம் , கிறிஸ்டோபர் ஜ்ட் வாலிஸ் , வாண்டர்பில்ட் பல்கலைக்கழகம் மருத்துவ மையம் , சர்வதேச கிருமி செல் புற்றுநோய் கூட்டு குழு , உலகளாவிய சமூகம் , ஐரோப்பிய சிறுநீரகம் , ஒன்றுபட்டது கிஂக்டம் அடிப்படையிலானது ,